Lv52
860 积分 2024-12-14 加入
Characterization of Ligand Binding to Pseudokinases Using a Thermal Shift Assay
5天前
已关闭
IRF4 in multiple myeloma—Biology, disease and therapeutic target
20天前
已完结
IRF4 addiction in multiple myeloma
22天前
已完结
CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer
1个月前
已完结
Discovery and Evaluation of Clinical Candidate AZD3759, a Potent, Oral Active, Central Nervous System-Penetrant, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
1个月前
已完结
Antitumor activity of HM781‐36B, a highly effective pan‐HER inhibitor in erlotinib‐resistant NSCLC and other EGFR‐dependent cancer models
1个月前
已完结
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
1个月前
已完结
The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
1个月前
已完结
Janus kinase inhibitor monotherapy and combination therapies for myelofibrosis: what’s the current standard of care?
2个月前
已完结
Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms
2个月前
已完结
皖公网安备34019202002308
